Primary Immune Deficiency Disorder Clinical Trials in Los Angeles, California
3 recruitingLos Angeles, California
Showing 1–3 of 3 trials
Recruiting
Phase 2
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College20 enrolled8 locationsNCT03266653
Recruiting
Phase 2
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
AdenovirusPrimary Immune Deficiency Disorder
New York Medical College20 enrolled10 locationsNCT03266627
Recruiting
Phase 2
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College20 enrolled9 locationsNCT03266640